KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD

By sjmartinez • December 25, 2023

Mottl AK, Nicholas SB. KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD. Am J Kidney Dis. 2023 Dec 21:S0272-6386(23)00883-1. doi: 10.1053/j.ajkd.2023.09.003. Epub ahead of print. PMID: 38142396.

Tags: Chronic kidney disease, commentary, diabetes, evidence-based recommendation, GLP-1 RAs, guideline, guideline implementation, Nephrology, nephrology best practices, ns-MRAs, Publications, SGLT2 inhibitors

GFR indexing per Body surface area -Why, how and when?

Delanaye P, Pottel H, Glassock RJ. GFR indexing per Body surface area -Why, how and when? Nephrol Dial Transplant. 2026 Jun 12:gfag138. doi: 10.1093/ndt/gfag138. Epub[...]

Heterogeneous evolution of pancreatic cancer microvasculature revealed by longitudinal intravital imaging

Lucia SE, Hong S, Abdi R, Kim P. Heterogeneous evolution of pancreatic cancer microvasculature revealed by longitudinal intravital imaging. Cancer Cell Int. 2026 Jun 12.[...]

Discovery of Endothelial Cell Antibodies Associated with Pediatric and Adult Kidney Allograft Rejection and Assessment of a non-HLA Antibody Assay

Butler CL, Hickey MJ, Pearl MH, Zheng Y, Gjertson D, Sunga G, Chen L, Vangala S, Elashoff D, Weng P, Lum E, Bunnapradist S, Abdalla[...]